Search clinical trials for: PR Oxycodone

Total 656 results

University Hospital, Toulouse

Completed

Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease (OXYDOPA)

Parkinson Disease

France
Mundipharma SAS

Terminated

Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients (OXN3505)

Pain | Constipation

France
Mundipharma Research GmbH & Co KG

Completed

A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy

Pain | Constipation

United Kingdom
Kuopio University Hospital
Admescope Ltd

Active, not recruiting

The Safety and Efficacy of Epidural Oxycodone (epioksipanu)

Pain, Postoperative

Finland
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Pain | Cancer

China
Kuopio University Hospital
Admescope Ltd

Recruiting

Oxycodone in Treatment of Early Labour Pain Efficacy and Safety (oksisynnytys)

Labor Pain

Finland
Fondazione Salvatore Maugeri

Completed

Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial

Chronic Obstructive Pulmonary Disease

Italy
University of Alberta
McGill University; Université de Sherbrooke; University of Toronto

Completed

The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial (CoNSPiRE)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
University of Glasgow
NHS Research and Development

Completed

An Evaluation of Web Based Pulmonary Rehabilitation (webbasedPR)

Chronic Obstructive Pulmonary Disease

United Kingdom
Mundipharma Research GmbH & Co KG

Completed

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Moderate to Severe Idiopathic RLS With Daytime Symptoms

Spain, Sweden, Germany
Vedic Lifesciences Pvt. Ltd.

Completed

Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain

Joint Pain

India
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family Members

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Ensysce Biosciences
Dr. Vince Clinical Research

Completed

A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users

Recreational Drug Use

United States
Mundipharma Oy

Completed

OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty (OXN4505)

Post Operative Pain

Finland
Vedic Lifesciences Pvt. Ltd.

Completed

A Study to Evaluate the Efficacy of E-PR-01 on Musculoskeletal Health in Physically Active Individuals

Joint Pain

India
Mallinckrodt

Completed

Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets

Healthy

United States
University Hospital, Brest

Recruiting

Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study (RAMBO)

Pulmonary Embolism | Quality of Life and Dyspnea

France
McMaster University

Recruiting

Impact of Pulmonary Rehabilitation on Loneliness in COPD

Loneliness

Canada
University of British Columbia

Completed

Sprint Snacks: The Effects of Prolonged Rest on Reduced Exertion Interval Training.

Cardiorespiratory Fitness

Canada
London School of Hygiene and Tropical Medicine
Wellcome Trust

Completed

Experimental Study to Assess Interventions Aimed at Improving the Equity Impact of Community-Based Health Insurance

Health Insurance

India
Mallinckrodt

Completed

Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets

Healthy

United States
Mallinckrodt

Completed

Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets

Healthy

United States
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

Portugal
Grünenthal GmbH

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects

Pharmacokinetics

Germany
Chang Gung Memorial Hospital

Unknown

Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD)

Osteoporosis | COPD,

Taiwan
University of Nebraska
National Cancer Institute (NCI); Amgen

Completed

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma

United States
Pfizer

Completed

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Healthy

United States
Göteborg University

Recruiting

RCT of PR-ESSENCE - a Problem Solving Model for Youth With Challenging Behavior in Special (SiS) Treatment Homes

Neurodevelopmental Disorders | Behavior Problems

Sweden
University of Alberta
University of Calgary

Completed

Examining Pulmonary Rehabilitation on Discharged COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Amgen

Completed

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Renal Insufficiency | Multiple Myeloma

United States
Mundipharma Research GmbH & Co KG

Completed

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (HMX3501)

Constipation

Romania, Switzerland, Israel, Belgium, Germany, Australia, Austria, Czech Republic, Denmark, Finland, France, Netherlands, Poland, United Kingdom
Columbia University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD (CALM)

COPD

United States
Sociedad Española de Neumología y Cirugía Torácica

Completed

Cost/Effectiveness Analysis of the Respiratory Poligraphy at Home (Telesleep)

Suspected Sleep Apnea | Daytime Sleepiness

Spain
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Pain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative...

United States
Göteborg University

Completed

PR-ESSENCE for Youth With Challenging Behavior

Behavior Problem of Childhood and Adolescence
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Effectiveness of Harmonica Playing in Improving Lung Function Among COPD Patients

COPD

China
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Effects of Garlic Supplements on Opioids in Healthy Volunteers

Healthy, No Evidence of Disease

United States
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

Obesity | Obstructive Sleep Apnea

United States
University of Oklahoma

Active, not recruiting

Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms

Vaginal Prolapse

United States
Amgen

Completed

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Multiple Myeloma | Solid Tumors

United States, Canada
AdvanceCor GmbH
Procorde GmbH

Completed

Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion (PR-15/01)

Myocardial Infarction | Stroke | Thrombosis | Acute Coronary Syndrome

Germany
Poznan University of Medical Sciences

Completed

Oxycodone (10, 20 mg) in a Postoperative Dressing

Burns
Proacta, Incorporated

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Proacta, Incorporated
National Cancer Institute (NCI)

Completed

PR-104 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Mayo Clinic

Recruiting

Breathing Training and Exercise Capacity in Non-CFB

Non-cystic Fibrosis Bronchiectasis

United States
Marmara University

Unknown

The Effect of Body Awareness Therapy on Postural Stability, Balance and Fear of Falling in Patients With COPD

Asthma

Turkey
Aveiro University

Completed

Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD

Pulmonary Disease, Chronic Obstructive
Mount Carmel Health System

Withdrawn

Impact of the Number of Opiates Prescribed on Post Cesarean Pain Control

Post-operative Pain Control

United States
Sharon Walsh
National Institute on Drug Abuse (NIDA); Merck Sharp & Dohme LLC

Completed

Aprepitant Effects on Oxycodone Response

Narcotic Abuse

United States
Grünenthal GmbH

Completed

A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure

Substance Abuse

Canada

Search clinical trials for: PR Oxycodone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations